Laura J. Henze

Laura J. Henze

Auto-generated profile, based on publicly available information

Laura J. Henze

School of Pharmacy, University College Cork, Cork, Ireland

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Closed access
PDF file
LHLaura J. Henze
Laura J. Henze
NKNiklas J. Koehl
Niklas J. Koehl
JOJoseph O’Shea
Joseph O’Shea
EKEdmund S. Kostewicz
Edmund S. Kostewicz
RHRené Holm
René Holm
BGBrendan Griffin
Brendan Griffin

1 December 2019 in International Journal of Pharmaceutics: X
Verified
Journal Article
Open access
LHLaura J. Henze
Laura J. Henze
NKNiklas J. Koehl
Niklas J. Koehl
JOJoseph O’Shea
Joseph O’Shea
RHRené Holm
René Holm
MVMaria Vertzoni
Maria Vertzoni
BGBrendan Griffin
Brendan Griffin
A preclinical porcine model that reliably predicts human food effect of fenofibrate was developed. Fenofibrate was administered to pigs as model compound with a positive food effect. Two different types of fed conditions were explored: a FDA style breakfast and a standard pig pellet feed. In order to assess if complete stomach emptying had been achieved under the employed fasting protocol, the amount of gastric and intestinal content was evaluated post-mortem. In addition, the protocol was designed to evaluate gastric emptying in the pre- and postprandial state using paracetamol as a marker. The study confirmed that micronized fenofibrate displayed a positive food effect with a similar fold difference to humans in FDA style fed state. Post-mortem assessment of stomach and intestinal content confirmed significantly lower content in the fasted compared to the pig pellet fed state. In the case of paracetamol, a delayed gastric emptying in the fed state was not observed, which may suggest that the Magenstrasse phenomena reported in humans, may also occur in landrace pigs. The study demonstrated the utility of a food effect protocol in landrace pigs as a pre-clinical approach to predict human food effects and provided new insights into gastric emptying in pigs.

29 August 2025 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
HKHannah S. Kirschbaum
Hannah S. Kirschbaum
NKNiklas J. Koehl
Niklas J. Koehl
JBJohannes A. Blechar
Johannes A. Blechar
CWChristina Wiesinger
Christina Wiesinger
LKLaura J. Koehl
Laura J. Koehl
BGBrendan Griffin
Brendan Griffin
The pH stat in vitro lipolysis method is well established for evaluating lipid-based formulations (LBFs), however the absence of a simulated gastrointestinal transition may lead to an overestimation of drug precipitation particularly in the case of weakly basic drugs. This study aimed to compare the conventional pH-stat method with a pH-shift lipolysis approach by evaluating a diverse set of LBFs using nilotinib, a weakly basic model drug. Additionally, the study sought to assess in vitro-in vivo relationships (IVIVRs) and enhance understanding of the predictive capabilities of these models. Four nilotinib-containing LBFs were tested in vitro, and pharmacokinetic profiles were evaluated in Sprague Dawley rats. The formulations included a supersaturated Peceol® solution (sLBF), a Peceol® lipid suspension (type I according to the Lipid Formulation Classification System (LFCS)), a type III LFCS medium-chain suspension, and a type IV LFCS suspension. The highest bioavailability was achieved with the Peceol® sLBF and the type III LFCS formulation. Strong IVIVRs were established for both in vitro lipolysis models. In conclusion, utilizing both in vitro models offered distinct advantages depending on the stage of development and the specific questions being addressed. This approach contributes to more efficient formulation development and a reduced reliance on animal studies in early-stage drug development.

1 April 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
HKHannah Sofie Kirschbaum
Hannah Sofie Kirschbaum
CJChristian Jede
Christian Jede
LKLaura J. Koehl
Laura J. Koehl
MKMartin Kuentz
Martin Kuentz
René HolmRené Holm
René Holm
POPatrick J. Odwyer
Patrick J. Odwyer
Lipid-based‑formulations (LBFs) are widely used to improve oral bioavailability of poorly water‑soluble drugs. Despite their widespread use in predicting formulation performance, standard in vitro lipolysis assays often lack an absorptive sink and fail to capture the transition from gastric to intestinal environments, thereby reducing their predictive relevance for in vivo outcomes. The aim of this study was to develop a biphasic in vitro lipolysis model incorporating an absorptive sink. In this model, the absorptive sink was provided by a decanol layer, and to simulate gastrointestinal transit, two dynamic pH‑transition approaches were employed: a biphasic GI‑transfer model and a biphasic pH‑shift model. Using nilotinib‑loaded LBFs, the study established conditions for this biphasic system and examined how media composition and lipase source influence drug concentrations during formulation dispersion, digestion, and partitioning into the organic sink. The results showed that digestion experiments conducted with either porcine pancreatin or Palatase® 20000 L increased the concentration of nilotinib in the aqueous digestion medium, which correspondingly reduced partitioning of the drug into the decanol layer. For the readily dispersible Type III LBF in the biphasic GI‑transfer setup, nilotinib permeation into the decanol layer decreased compared with a lipid‑free control, likely due to improved drug solubilization in the aqueous digestion phase. In contrast, the poorly dispersible Type I LBF was better suited to the biphasic pH‑shift setup, but it showed higher drug levels in the decanol layer, reflecting rapid partitioning of lipids—and associated crystalline drug—into the organic phase. Overall, this study establishes suitable conditions for evaluating the lipolysis of LBFs during a dynamic pH transition in the presence of an absorptive sink. This advanced approach provides additional insight to explore digestion‑mediated and/or pH‑mediated supersaturation during digestion of LBFs.